Cargando…
Fibroblast growth factor 21 ameliorates behavior deficits in Parkinson's disease mouse model via modulating gut microbiota and metabolic homeostasis
AIMS: The effects of FGF21 on Parkinson's disease (PD) and its relationship with gut microbiota have not been elucidated. This study aimed to investigate whether FGF21 would attenuate behavioral impairment through microbiota–gut–brain metabolic axis in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridi...
Autores principales: | Yang, Changwei, Wang, Wuqiong, Deng, Pengxi, Wang, Xinyi, Zhu, Lin, Zhao, Liangcai, Li, Chen, Gao, Hongchang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651963/ https://www.ncbi.nlm.nih.gov/pubmed/37334756 http://dx.doi.org/10.1111/cns.14302 |
Ejemplares similares
-
Fibroblast Growth Factor 21 Modulates Microglial Polarization That Attenuates Neurodegeneration in Mice and Cellular Models of Parkinson's Disease
por: Yang, Changwei, et al.
Publicado: (2021) -
Brain-Region Specific Metabolic Abnormalities in Parkinson’s Disease and Levodopa-Induced Dyskinesia
por: Yang, Changwei, et al.
Publicado: (2020) -
Sodium butyrate ameliorates gut dysfunction and motor deficits in a mouse model of Parkinson’s disease by regulating gut microbiota
por: Zhang, Yi, et al.
Publicado: (2023) -
Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson’s disease
por: Cui, Can, et al.
Publicado: (2022) -
Faecal microbiota transplant ameliorates gut dysbiosis and cognitive deficits in Huntington’s disease mice
por: Gubert, Carolina, et al.
Publicado: (2022)